Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Supporters often highlight the possibility for meaningful therapeutic gains, especially in diseases where conventional medications have proven limited. However, crucially important to evaluate the substantial financial expenditure associated with CPI